• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Cigna Ventures | Health Care Venture Capital

Cigna Ventures | Health Care Venture Capital

  • Strategy
  • Partners
  • Team
  • Case Studies
  • News
  • Contact

Evernorth Completes Acquisition of MDLIVE to Expand Access to Virtual Care

April 19, 2021

Evernorth, the health services portfolio of Cigna Corporation, announced that it has completed its acquisition of MDLIVE, a privately held, leading 24/7 virtual care delivery platform. The transaction, first announced on February 26, expands Evernorth’s capabilities to lower the cost of care – while increasing access to health care providers – through virtual visits that can be accessed from the home or anywhere.

Read the full article

Filed Under: News

Primary Sidebar

Categories

  • News
  • Partnership Activity

More news

  • Evernorth’s New Behavioral Care Practice Offers Quality Care To Improve Mental Well-Being March 13, 2024
  • 9amHealth Raises $9.5M Series A Extension Led by The Cigna Group Ventures to Expand to Employers Nationwide February 20, 2024
  • Prognos Health Raises $23 Million May 11, 2023
  • Monogram Health’s In-Home Services Now Available to More Older Adults Living with Chronic Kidney Conditions February 7, 2023
  • NOCD Completes Additional Funding in its Quest to End the OCD Crisis January 31, 2023
  • Monogram Health Closes $375M Growth Capital Raise to Support Continued Expansion of Innovative In-Home Kidney and Polychronic Care Model January 13, 2023
  • Valera Health Announces $45 Million Growth Equity Financing to Increase Access to Evidence-based Mental Health Services for High Acuity Patients October 31, 2022

Footer

  • Strategy
  • Partners
  • Team
  • Case Studies
  • News
  • Contact

By contacting The Cigna Group Ventures through this website, you agree and acknowledge that information you submit will not be considered or treated as confidential or proprietary unless and until a separate agreement is signed and that The Cigna Group Ventures and its affiliates are under no obligation to review your submission or to enter into any agreement, investment or transaction associated with the submission. In no event will The Cigna Group Ventures or any of its affiliates be limited in, or restricted from, the pursuit of any opportunities, either alone or with third parties.

The information contained herein does not constitute a distribution, an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction in which such distribution or offer is not authorized. In particular, the information herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States (U.S.) or for the benefit of any U.S. person (being residents of the United States or partnerships or corporations organized under the laws of the United States), nor in any other country.

The Cigna Group name, logo and other marks are owned by Cigna Intellectual Property, Inc.
Privacy Policy | Terms of Use | Accessibility | Cookie Settings
© 2024 The Cigna Group Ventures. All rights reserved.

This site is protected by Google's reCAPTCHA. Privacy Policy and Terms of Service apply.